cycloviracin B1: structure given in first source; isolated from Kibdelosporangium albatum [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 132423 |
| MeSH ID | M0208383 |
| Synonym |
|---|
| 142382-45-4 |
| bu 4224v-b1 |
| 3-(16,22-bis((2-o-methyl-beta-d-glucopyranosyl)oxy)tricosyl)-9,10,11,20,21,22-hexahydroxy-14-(20-hydroxy-14-((2-o-methyl-beta-d-glucopyranosyl)oxy)heneicosyl)-2,6,13,17,23,24-hexaoxatricyclo(17.3.1.1(8,12))tetracosane-5,16-dione |
| cycloviracin-b1 |
| 2,6,13,17,23,24-hexaoxatricyclo(17.3.1.1(8,12))tetracosane-5,16-dione, 3-(16,22-bis((2-o-methyl-beta-d-glucopyranosyl)oxy)tricosyl)-9,10,11,20,21,22-hexahydroxy-14-(20-hydroxy-14-((2-o-methyl-beta-d-glucopyranosyl)oxy)heneicosyl)- |
| cycloviracin b1 |
| 3-[16,22-bis[[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy]tricosyl]-14-[14-[(2r,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy-20-hydroxyhenicosyl]-9,10,11,20,21,22-hexahydroxy-2,6,13,17,23,24-hexaoxatricyc |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||